```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[S. 2338 Reported in Senate (RS)]

                                                       Calendar No. 608
113th CONGRESS
  2d Session
                                S. 2338

                          [Report No. 113-281]

  To reauthorize the United States Anti-Doping Agency, and for other 
                               purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 14, 2014

Mr. Rockefeller (for himself, Mr. Thune, and Mr. Blunt) introduced the 
 following bill; which was read twice and referred to the Committee on 
                 Commerce, Science, and Transportation

                            December 1, 2014

             Reported by Mr. Rockefeller, without amendment

_______________________________________________________________________

                                 A BILL

 
  To reauthorize the United States Anti-Doping Agency, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``United States Anti-Doping Agency 
Reauthorization Act''.

SEC. 2. PROHIBIT PERFORMANCE-ENHANCING METHODS.

    Section 701 of title VII of the Office of National Drug Control 
Policy Reauthorization Act of 2006 (21 U.S.C. 2001) is amended--
            (1) in subsection (a), by striking paragraph (4); and
            (2) in subsection (b)--
                    (A) in paragraph (1), by inserting ``and be 
                recognized worldwide as the independent national anti-
                doping organization for the United States'' after 
                ``Committee'';
                    (B) in paragraph (2), by striking ``, or 
                performance-enhancing genetic modifications 
                accomplished through gene-doping'' and inserting ``or 
                prohibited performance-enhancing methods adopted by the 
                Agency'';
                    (C) in paragraph (3), by striking ``, or 
                performance-enhancing genetic modifications 
                accomplished through gene-doping'' and inserting ``or 
                prohibited performance-enhancing methods adopted by the 
                Agency'';
                    (D) in paragraph (4), by striking ``and the 
                prevention of use of performance-enhancing drugs, or 
                performance-enhancing genetic modifications 
                accomplished through gene-doping by United States 
                amateur athletes; and'' and inserting ``, and the 
                prevention of use by United States amateur athletes of 
                performance-enhancing drugs or prohibited performance-
                enhancing methods adopted by the Agency.''; and
                    (E) by striking paragraph (5).

SEC. 3. AUTHORIZATION OF APPROPRIATIONS.

    Section 703 of title VII of the Office of National Drug Control 
Policy Reauthorization Act of 2006 (21 U.S.C. 2003) is amended to read 
as follows:

``SEC. 703. AUTHORIZATION OF APPROPRIATIONS.

    ``There are authorized to be appropriated to the United States 
Anti-Doping Agency--
            ``(1) for fiscal year 2014, $11,300,000;
            ``(2) for fiscal year 2015, $11,700,000;
            ``(3) for fiscal year 2016, $12,300,000;
            ``(4) for fiscal year 2017, $12,900,000;
            ``(5) for fiscal year 2018, $13,500,000;
            ``(6) for fiscal year 2019, $14,100,000; and
            ``(7) for fiscal year 2020, $14,800,000.''.
                                                       Calendar No. 608

113th CONGRESS

  2d Session

                                S. 2338

                          [Report No. 113-281]

_______________________________________________________________________

                                 A BILL

  To reauthorize the United States Anti-Doping Agency, and for other 
                               purposes.

_______________________________________________________________________

                            December 1, 2014

                       Reported without amendment
```